Virginia Beach-based LifeNet Health, a regenerative medicine company, has acquired the assets of Samsara Sciences, a San Diego-based life sciences company.
Financial details of the deal were not disclosed.
Samsara specializes in human primary liver and kidney cell isolation. The acquisition includes Samsara's equipment, inventory and associated technology.
"These assets complement our primary cell programs, which provide vital resources for discovering safe, effective new therapies," Rony Thomas, LifeNet’s president and CEO, said in a statement. "We continue to invest in this area and collaborate closely with pharmaceutical and biomedical research organizations to support breakthroughs in patient care."
